Signal transducer and activator of transcription 5 is implicated in disease activity in adult and juvenile onset systemic lupus erythematosus
- 4 April 2016
- journal article
- research article
- Published by Springer Nature in Clinical Rheumatology
- Vol. 35 (6) , 1515-1520
Abstract
The Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway is one of a handful of pleiotropic cascades used to transduce a multitude of signals for development and homeostasis in humans. It is the principal signaling mechanism for a wide array of cytokines and growth factors. Dysregulated cytokine action on immune cells plays an important role in the initiation and progress of systemic lupus erythematosus (SLE). In this study, we tried to assess the role of STAT5 in systemic lupus erythematosus and correlate its phosphorylation level with the disease activity. The activation of the STAT5 was assessed by measuring the level of expression of phosphorylated STAT5 (pSTAT5) using flow cytometry on the peripheral blood T and B cells in 58 SLE patients (40 adult and 18 juvenile onset) and on 23 healthy age- and sex-matched controls for both groups. Serum prolactin level was also assessed in the patients and control by ELISA. The study revealed that the level of pSTAT5 was higher in adult SLE patients than in healthy control (p = 0.001) and in juvenile-onset SLE patients versus age-matched control (p = 0.031). A positive correlation existed between the pSTAT5 levels and Systemic Lupus Activity Measure (SLAM) score and also with multiple clinical manifestations indicating a potential role of STAT5 signaling in pathogenesis SLE. The pSTAT5 signaling is implicated in the disease activity of SLE and may be a useful target of therapy by correcting the dysregulation of cytokines involved in the disease pathogenesis.Keywords
This publication has 32 references indexed in Scilit:
- Juvenile systemic lupus erythematosus onset patterns in Vietnamese children: a descriptive study of 45 childrenPediatric Rheumatology, 2012
- Emerging therapies for systemic lupus erythematosus — Focus on targeting interferon-alphaClinical Immunology, 2012
- Multidimensional Single Cell Based STAT Phosphorylation Profiling Identifies a Novel Biosignature for Evaluation of Systemic Lupus Erythematosus ActivityPLOS ONE, 2011
- Differential activation of JAK enzymes in rheumatoid arthritis and autoimmune disorders by pro-inflammatory cytokines: potential drug targetsInternational Journal of Interferon, Cytokine and Mediator Research, 2010
- Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5BGenes & Development, 2008
- Genomic view of systemic autoimmunity in MRLlpr miceGenes & Immunity, 2006
- Signal transduction in CD4+CD25+ regulatory T cells: CD25 and IL-2Frontiers in Bioscience-Landmark, 2006
- Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activityRheumatology, 2005
- STATs: transcriptional control and biological impactNature Reviews Molecular Cell Biology, 2002
- JAKS AND STATS: Biological ImplicationsAnnual Review of Immunology, 1998